Blockchain Registration Transaction Record

Cardio Diagnostics Revolutionizes Heart Disease Detection with AI-Powered Blood Test

Cardio Diagnostics uses AI, epigenetics & genetics to detect heart disease via blood test. Non-invasive, no fasting needed. CMS reimbursement secured, expanding globally.

This development represents a significant advancement in cardiovascular medicine with far-reaching implications for public health. Cardiovascular disease remains the leading cause of death in the United States, and traditional diagnostic methods often fail to detect certain forms of coronary heart disease until they become serious. Cardio Diagnostics' approach could enable earlier detection and more personalized treatment plans, potentially saving lives and reducing healthcare costs. The non-invasive nature of the test (requiring only a blood sample with no fasting or radiation) makes it more accessible and comfortable for patients. With CMS reimbursement now established and international expansion underway, this technology could soon become widely available, transforming how cardiovascular disease is prevented, detected, and managed globally.